SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001615774-16-006802
Filing Date
2016-08-15
Accepted
2016-08-15 16:38:13
Documents
61
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q s103890_10q.htm 10-Q 490513
2 EXHIBIT 10.1 s103890_ex10-1.htm EX-10.1 152609
3 EXHIBIT 31.1 s103890_ex31-1.htm EX-31.1 9167
4 EXHIBIT 31.2 s103890_ex31-2.htm EX-31.2 9153
5 EXHIBIT 32.1 s103890_ex32-1.htm EX-32.1 3805
6 EXHIBIT 32.2 s103890_ex32-2.htm EX-32.2 3760
7 GRAPHIC tpg17.jpg GRAPHIC 74484
14 GRAPHIC tpg1.jpg GRAPHIC 109900
15 GRAPHIC tlogo.jpg GRAPHIC 21387
16 GRAPHIC tlogo1.jpg GRAPHIC 10354
  Complete submission text file 0001615774-16-006802.txt   3305529

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE heb-20160630.xml EX-101.INS 456820
9 XBRL SCHEMA FILE heb-20160630.xsd EX-101.SCH 29134
10 XBRL CALCULATION FILE heb-20160630_cal.xml EX-101.CAL 42558
11 XBRL DEFINITION FILE heb-20160630_def.xml EX-101.DEF 148443
12 XBRL LABEL FILE heb-20160630_lab.xml EX-101.LAB 261932
13 XBRL PRESENTATION FILE heb-20160630_pre.xml EX-101.PRE 229354
Mailing Address 1617 JFK BLVD, SUITE #500 ONE PENN CENTER PHILADELPHIA PA 19103
Business Address 1617 JFK BLVD, SUITE #500 ONE PENN CENTER PHILADELPHIA PA 19103 215-988-0080
HEMISPHERX BIOPHARMA INC (Filer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-27072 | Film No.: 161833345
SIC: 2836 Biological Products, (No Diagnostic Substances)